Cas 858954-57-1,2-(3-chlorophenyl)-N'-[(1E)-(2-hydroxyphenyl)methylidene]acetohydrazide

858954-57-1

Post Buying Request

Basic information

Product Name: 2-(3-chlorophenyl)-N'-[(1E)-(2-hydroxyphenyl)methylidene]acetohydrazide
Synonyms: 2-(3-chlorophenyl)-N'-[(1E)-(2-hydroxyphenyl)methylidene]acetohydrazide
CAS NO:858954-57-1
Molecular Formula:
Molecular Weight: 288.733
EINECS: N/A
Product Categories: N/A
Mol File: 858954-57-1.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 2-(3-chlorophenyl)-N'-[(1E)-(2-hydroxyphenyl)methylidene]acetohydrazide(CAS DataBase Reference)
NIST Chemistry Reference: 2-(3-chlorophenyl)-N'-[(1E)-(2-hydroxyphenyl)methylidene]acetohydrazide(858954-57-1)
EPA Substance Registry System: 2-(3-chlorophenyl)-N'-[(1E)-(2-hydroxyphenyl)methylidene]acetohydrazide(858954-57-1)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 858954-57-1(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

858954-57-1 Suppliers

Recommended suppliersmore

858954-57-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 858954-57-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,8,9,5 and 4 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 858954-57:
(8*8)+(7*5)+(6*8)+(5*9)+(4*5)+(3*4)+(2*5)+(1*7)=241
241 % 10 = 1
So 858954-57-1 is a valid CAS Registry Number.

858954-57-1Upstream product

858954-57-1Downstream Products

858954-57-1Relevant articles and documents

INHIBITORS OF HCV NS5B POLYMERASE

-

Page/Page column 85, (2008/06/13)

The present invention relates to compounds, process for their synthesis, compositions and methods for the treatment and prevention of hepatitis C virus (HCV) infection. In particular, the present invention provides novel compounds, pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment or prevention of HCV infection. The present invention also provides processes and intermediates for the synthesis of these compounds.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 858954-57-1